Avity Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-435
Closed -$226K 110
2024
Q3
$226K Hold
435
0.02% 104
2024
Q2
$236K Sell
435
-50
-10% -$26.4K 0.02% 98
2024
Q1
$251K Buy
485
+44
+10% +$21.9K 0.02% 99
2023
Q4
$208K Buy
+441
New +$204K 0.02% 101
2023
Q2
Sell
-441
Closed -$203K 93
2023
Q1
$203K Sell
441
-81
-16% -$38.5K 0.02% 90
2022
Q4
$268K Buy
522
+62
+13% +$31.5K 0.03% 74
2022
Q3
$209K Buy
+460
New +$220K 0.02% 76

Other funds holding ELV

Avity Investment Management's ELV Position: Q4 2024 in Review

Avity Investment Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 435 shares — an estimated $226K sold.

Avity Investment Management first reported a position in ELV in Q3 2022 and held it in 7 quarters. The position peaked at $268K in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Avity Investment Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Avity Investment Management sold 435 Elevance Health shares in Q4 2024, an estimated $226K.
  • Avity Investment Management first reported a position in Elevance Health in Q3 2022 and held it in 7 quarters.
  • Avity Investment Management's Elevance Health position peaked at $268K in Q4 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Avity Investment Management's 13F filing for Q4 2024, filed 14 Jan 2025.